EFFICACY OF MINI PCNL FOR RENAL STONES IN CHILDREN
DOI:
https://doi.org/10.52764/jms.26.34.2.1Keywords:
children, Renal stones, Percutaneous NephrolithotomyAbstract
OBJECTIVE: This study aimed to determine whether mini-percutaneous nephrolithotomy is effective for treating lower-pole renal stones in children.
MATERIALS AND METHODS: This descriptive case series study was conducted at the Department of Urology, Khyber Teaching Hospital, Peshawar, from July 2021 to January 2022 (following approval of the study protocol by the Institutional Ethical Review Committee) and included 148 pediatric patients with a single lower-pole renal stone measuring 1.5 to 2 cm. Patients with prior renal surgery, multiple lower-pole renal stones, renal nephropathies, or anatomical abnormalities of the upper and lower renal systems were excluded. A pediatric urologist performed mini-PCNL on each patient in the prone position under general anesthesia. After injecting contrast (Urograffin) into the ureteric catheter, the renal tract was visualized using a fluoroscope.
RESULTS: The mean age and SD in this study were 9.75 ± 3.075. The baseline stone size mean and SD were 1.65 ± 0.17. Of the patients, 81 (54.7%) were younger than 10 years old, and 67 (45.3%) were older than 10 years. There were 45 female patients (30.4%) and 103 male patients (69.6%). According to rates and percentages indicating the effectiveness of mini-percutaneous nephrolithotomy in treating pediatric lower pole renal stones, 113 patients (76.4%) had their stones removed.
CONCLUSION: Based on its stone clearance rate and the absence of major complications, this study demonstrates that mini PCNL is a safe and effective treatment for lower-pole renal stones in children.
KEY WORDS: Children, Percutaneous Nephrolithotomy, and Renal Stone
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Tariq Ahmad, Murad Ali, Syed Muhammad, Sajjad Ali, Imdad Ullah, Ejaz Ullah
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
